secwatch.observer — SEC 8-K summary
======================================

Issuer:     MADRIGAL PHARMACEUTICALS, INC. (MDGL)
CIK:        0001157601
Form:       8-K
Filed at:   2022-06-17T23:59:59+00:00
Accession:  0001193125-22-176256
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Madrigal shareholders elect three Class III directors, ratify PwC, approve say-on-pay
--------------------------------------------------------------------------------

- Class III directors elected: Gollust 9.6M for/2.2M withheld, Levy 10.5M/1.3M, Milligan 11.6M/116K.
- Ratification of PricewaterhouseCoopers as auditor: 14.7M for, 19.8K against, 51K abstain.
- Advisory vote on executive compensation: 11.6M for, 111.9K against (99.0% of votes cast).
- Quorum of 14.78M shares present out of 17.10M outstanding as of April 27, 2022 record date.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1157601/000119312522176256/0001193125-22-176256-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1157601/000119312522176256/d318244d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-176256

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer